BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 31196016)

  • 21. Long-term continuous N-carbamylglutamate treatment in frequently decompensated propionic acidemia: a case report.
    Tummolo A; Melpignano L; Carella A; Di Mauro AM; Piccinno E; Vendemiale M; Ortolani F; Fedele S; Masciopinto M; Papadia F
    J Med Case Rep; 2018 Apr; 12(1):103. PubMed ID: 29679984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased plasma l-arginine levels in organic acidurias (MMA and PA) and decreased plasma branched-chain amino acid levels in urea cycle disorders as a potential cause of growth retardation: Options for treatment.
    Molema F; Gleich F; Burgard P; van der Ploeg AT; Summar ML; Chapman KA; Lund AM; Rizopoulos D; Kölker S; Williams M;
    Mol Genet Metab; 2019 Apr; 126(4):397-405. PubMed ID: 30827756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carglumic acid for the treatment of N-acetylglutamate synthase deficiency and acute hyperammonemia.
    Häberle J
    Expert Rev Endocrinol Metab; 2012 May; 7(3):263-271. PubMed ID: 30780843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylmalonic acidemia/propionic acidemia - the biochemical presentation and comparing the outcome between liver transplantation versus non-liver transplantation groups.
    Chu TH; Chien YH; Lin HY; Liao HC; Ho HJ; Lai CJ; Chiang CC; Lin NC; Yang CF; Hwu WL; Lee NC; Lin SP; Liu CS; Hu RH; Ho MC; Niu DM
    Orphanet J Rare Dis; 2019 Apr; 14(1):73. PubMed ID: 30940196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathophysiology of propionic and methylmalonic acidemias. Part 2: Treatment strategies.
    Haijes HA; van Hasselt PM; Jans JJM; Verhoeven-Duif NM
    J Inherit Metab Dis; 2019 Sep; 42(5):745-761. PubMed ID: 31119742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outpatient treatment of propionic acidemia-associated hyperammonemia with N-carbamoyl-L-glutamate in an infant.
    Soyucen E; Demirci E; Aydin A
    Clin Ther; 2010 Apr; 32(4):710-3. PubMed ID: 20435240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rhabdomyolysis in organic acidemia patients manifesting with metabolic decompensation.
    Kido J; Matsumoto S; Sawada T; Endo F; Nakamura K
    Hemodial Int; 2019 Oct; 23(4):E115-E119. PubMed ID: 31476111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergency presentations of patients with methylmalonic acidemia, propionic acidemia and branched chain amino acidemia (MSUD).
    Henriquez H; el Din A; Ozand PT; Subramanyam SB; al Gain SI
    Brain Dev; 1994 Nov; 16 Suppl():86-93. PubMed ID: 7726386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylmalonic and propionic acidemia among hospitalized pediatric patients: a nationwide report.
    Jiang YZ; Shi Y; Shi Y; Gan LX; Kong YY; Zhu ZJ; Wang HB; Sun LY
    Orphanet J Rare Dis; 2019 Dec; 14(1):292. PubMed ID: 31842933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver Transplantation for Propionic Acidemia and Methylmalonic Acidemia: Perioperative Management and Clinical Outcomes.
    Critelli K; McKiernan P; Vockley J; Mazariegos G; Squires RH; Soltys K; Squires JE
    Liver Transpl; 2018 Sep; 24(9):1260-1270. PubMed ID: 30080956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma methylcitric acid and its correlations with other disease biomarkers: The impact in the follow up of patients with propionic and methylmalonic acidemia.
    Maines E; Catesini G; Boenzi S; Mosca A; Candusso M; Dello Strologo L; Martinelli D; Maiorana A; Liguori A; Olivieri G; Taurisano R; Piemonte F; Rizzo C; Spada M; Dionisi-Vici C
    J Inherit Metab Dis; 2020 Nov; 43(6):1173-1185. PubMed ID: 32681732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Early Cost-Utility Model of mRNA-Based Therapies for the Treatment of Methylmalonic and Propionic Acidemia in the United Kingdom.
    Bretos-Azcona PE; Wallace M; Jootun M; Jin G; Agirrezabal I; Szende A
    Clin Drug Investig; 2024 Jun; 44(6):399-412. PubMed ID: 38796677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging trends in management of propionic acidemia.
    Rafique M
    Arq Bras Endocrinol Metabol; 2014 Apr; 58(3):237-42. PubMed ID: 24863085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene therapy for organic acidemias: Lessons learned from methylmalonic and propionic acidemia.
    Chandler RJ; Venditti CP
    J Inherit Metab Dis; 2024 Jan; 47(1):63-79. PubMed ID: 37530705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of liver transplantation in methylmalonic and propionic acidemias.
    Li M; Dick A; Montenovo M; Horslen S; Hansen R
    Liver Transpl; 2015 Sep; 21(9):1208-18. PubMed ID: 25990417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heptadecanoylcarnitine (C17) a novel candidate biomarker for newborn screening of propionic and methylmalonic acidemias.
    Malvagia S; Haynes CA; Grisotto L; Ombrone D; Funghini S; Moretti E; McGreevy KS; Biggeri A; Guerrini R; Yahyaoui R; Garg U; Seeterlin M; Chace D; De Jesus VR; la Marca G
    Clin Chim Acta; 2015 Oct; 450():342-8. PubMed ID: 26368264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding acute metabolic decompensation in propionic and methylmalonic acidemias: a deep metabolic phenotyping approach.
    Haijes HA; Jans JJM; van der Ham M; van Hasselt PM; Verhoeven-Duif NM
    Orphanet J Rare Dis; 2020 Mar; 15(1):68. PubMed ID: 32143654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterizing the mechanism of action for mRNA therapeutics for the treatment of propionic acidemia, methylmalonic acidemia, and phenylketonuria.
    Baek R; Coughlan K; Jiang L; Liang M; Ci L; Singh H; Zhang H; Kaushal N; Rajlic IL; Van L; Dimen R; Cavedon A; Yin L; Rice L; Frassetto A; Guey L; Finn P; Martini PGV
    Nat Commun; 2024 May; 15(1):3804. PubMed ID: 38714648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver and/or kidney transplantation in amino and organic acid-related inborn errors of metabolism: An overview on European data.
    Molema F; Martinelli D; Hörster F; Kölker S; Tangeraas T; de Koning B; Dionisi-Vici C; Williams M;
    J Inherit Metab Dis; 2021 May; 44(3):593-605. PubMed ID: 32996606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of medical food leucine content in the management of methylmalonic and propionic acidemias.
    Myles JG; Manoli I; Venditti CP
    Curr Opin Clin Nutr Metab Care; 2018 Jan; 21(1):42-48. PubMed ID: 29035969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.